TNFSF15 Antikörper
Kurzübersicht für TNFSF15 Antikörper (ABIN3071877)
Target
Alle TNFSF15 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Verwendungszweck
- Anti-VEGI Unconjugated Antibody
-
Produktmerkmale
- Vascular endothelial cell growth inhibitor (VEGI), a member of the tumor necrosis factor (TNF) family, is an endothelial cell-specific inhibitor of angiogenesis. Overexpression of a secretable VEGI fusion protein by cancer cells resulted in abrogation of xenograft tumor progression. 4-3H8B is a mouse monoclonal IgG1 raised against a recombinant VEGI isoform which shares a C-terminal 151-residue segment with previously reported VEGI with 174 residues.
-
Aufreinigung
- Purified
-
Reinheit
- >95 %
-
Immunogen
- Recombinant VEGI isoforms
-
Isotyp
- IgG2b, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- PBS pH 7.2, 0.1 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
-
- TNFSF15 (Tumor Necrosis Factor (Ligand) Superfamily, Member 15 (TNFSF15))
-
Andere Bezeichnung
- VEGI
-
UniProt
- O95150
-
Pathways
- Positive Regulation of Endopeptidase Activity, Autophagie
Target
-